BioAnalytix works with pharmaceutical partners for the development and commercialization of biologic and biosimilar drugs.
Bioanalytix is a pharmaceutically oriented commercial spin out from the Barnett institute of chemical and Biological Analysis at Northeastern university in Boston,MA. Founded by thought leaders in clinical development, regulatory strategy, and advanced analytics,Bioanaytix is working wiht leading Pharmaceutical partners to advance, improve and accelerate the development and commercialization of biologic and biosimilar drugs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 24, 2013 | Series Unknown | $3.75M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Relativity Healthcare Partners | — | Series Unknown |